Chris Beaver joins Pharmanet as Director, Immunochemistry Services
Dr. Beaver’s appointment strengthens PharmaNet’s offerings in large molecule bioanalytical services to support the growing interest in biologics and biosimilars within the pharmaceutical industry. PharmaNet has two GLP-compliant bioanalytical laboratories which are located in Princeton, New Jersey and Quebec City, Canada.
Previously, Dr. Beaver served as Scientific Director of Ligand Binding/Cell Based Assays at another clinical research organization with macromolecule bioanalysis operations. He completed his Ph.D. in Neuroscience at Dalhousie University in Halifax, Canada, followed by post-doctoral training at Yale University. Dr. Beaver is published in multiple scientific publications, including Drug Discovery World and Nature Neuroscience.
Other news from the department people
These products might interest you
Most read news
More news from our other portals
See the theme worlds for related content
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.
Topic World Cell Analysis
Cell analyse advanced method allows us to explore and understand cells in their many facets. From single cell analysis to flow cytometry and imaging technology, cell analysis provides us with valuable insights into the structure, function and interaction of cells. Whether in medicine, biological research or pharmacology, cell analysis is revolutionizing our understanding of disease, development and treatment options.